Cargando…

Ilheus and Saint Louis encephalitis viruses elicit cross-protection against a lethal Rocio virus challenge in mice

Rocio virus (ROCV) was the causative agent of an unprecedented outbreak of encephalitis during the 1970s in the Vale do Ribeira, Sao Paulo State, in the Southeast region of Brazil. Surprisingly, no further cases of ROCV infection were identified after this outbreak; however, serological surveys have...

Descripción completa

Detalles Bibliográficos
Autores principales: Amarilla, Alberto Anastacio, Fumagalli, Marcilio Jorge, Figueiredo, Mario Luis, Lima-Junior, Djalma S., Santos-Junior, Nilton Nascimento, Alfonso, Helda Liz, Lippi, Veronica, Trabuco, Amanda Cristina, Lauretti, Flavio, Muller, Vanessa Danielle, Colón, David F., Luiz, João P. M., Suhrbier, Andreas, Setoh, Yin Xiang, Khromykh, Alexander A., Figueiredo, Luiz Tadeu Moraes, Aquino, Victor Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999289/
https://www.ncbi.nlm.nih.gov/pubmed/29897990
http://dx.doi.org/10.1371/journal.pone.0199071
Descripción
Sumario:Rocio virus (ROCV) was the causative agent of an unprecedented outbreak of encephalitis during the 1970s in the Vale do Ribeira, Sao Paulo State, in the Southeast region of Brazil. Surprisingly, no further cases of ROCV infection were identified after this outbreak; however, serological surveys have suggested the circulation of ROCV among humans and animals in different regions of Brazil. Cross-protective immunity among flaviviruses is well documented; consequently, immunity induced by infections with other flaviviruses endemic to Brazil could potentially be responsible for the lack of ROCV infections. Herein, we evaluated the cross-protection mediated by other flaviviruses against ROCV infection using an experimental C57BL/6 mouse model. Cross-protection against ROCV infection was observed when animals had prior exposure to Ilheus virus or Saint Louis encephalitis virus, suggesting that cross-reactive anti-flavivirus antibodies may limit ROCV disease outbreaks.